Welcome to Emirates Drug Establishment

Delivering Tomorrow's Healthcare Solution Today

About Us

Established in 29 September 2023, The Emirates Drug Establishment (EDE) is the cornerstone of the UAE's transformative healthcare sector and the only federal authority responsible for regulating all medical and pharmaceutical products. This includes also medical devices, blood derivative products, genetically modified organisms, stem cells, medicated cosmetics, veterinary medications, and agriculture products. Setting unparalleled standards and a catalyst for groundbreaking innovation, we at EDE will foster a collaborative ecosystem that will position the UAE as a global beacon in healthcare.

Our Services

EDE’s vision is to build a transformative and dynamic healthcare ecosystem in the UAE. We collaborate with citizens, the government and businesses across services including regulating and promoting research and development, clinical and non-clinical trials, pharmaceutical testing, drug approval and registration, drug manufacturing, market authorization, pharmacovigilance, control and inspection.

individuals

For Individuals

Business

For Business

government

For Government

Chairman’s Message

Promoting the Healthcare Sector in the UAE: A Shared Vision

The UAE is pressing ahead with its efforts to reinforce its leading position as a global hub for healthcare and pharmaceutical excellence, driven by the wise leadership’s forward-looking vision to establish health and pharmaceutical security as two fundamental pillars sustaining development and promoting quality of life.

This mission is perfectly aligned with the country’s strategic approach aimed at building a diversified and sustainable economy fueled by innovation and knowledge, as well as enhancing the contribution of future-oriented sectors to the nation’s economic value, in line with "We the UAE 2031" and the "UAE Centennial 2071" visions.

Committed to a vision, the Emirates Drug Establishment is embarking on a new era of sustainable health and pharmaceutical leadership. Through active partnerships with relevant local and federal government entities, as well as the private sector, the Establishment aims to achieve integration between the healthcare system and pharmaceutical manufacturing.

This is because partnerships have become a strategic pillar that enhances the nation’s readiness, global competitiveness, and its role in advancing innovative pharmaceutical industries.

The Emirates Drug Establishment is therefore moving forward with confidence to consolidate the UAE’s position as a global hub for pharmaceutical innovation, which not only integrates artificial intelligence and emerging technologies, but also establishes an advanced institutional model in pharmaceutical governance and shape the future of healthcare sector.

To translate this vision into action, the Establishment is accelerating efforts to build robust national capabilities that fuel a sustainable pharmaceutical industry, ensure supply chain resilience and self-sufficiency, and elevate the UAE’s global standing as a model of knowledge, progress, and human-centered development.

H.E. Saeed Mubarak Rashid Al Hajeri
Minister of State, Chairman of the Board of Directors of the Emirates Drug Establishment
Authority

Chairman’s Message

Put Heading of message here...

Put the Chairman's message here

Saeed Mubarak Al Hajeri
Minister of State
Chairman, Board of Directors, Emirates Drug Establishment
Authority

Vice Chairman’s Message

A Shared Journey for Healthcare Innovation

The Emirates Drug Establishment (EDE) plays a pivotal role in shaping the nation’s healthcare future, as it remains dedicated to fulfilling its mission: ensuring patient safety, fostering innovation, and integrating global best practices.
At EDE, we believe a dynamic healthcare ecosystem thrives on collective action. It is only by partnering with government agencies, healthcare professionals, businesses, and the public, that we can build a world-class regulatory framework. A framework that is agile, science-driven, and informed by a global perspective. We aspire to be a springboard for groundbreaking healthcare advancements in the UAE and beyond. We aim to achieve this through a multi-pronged approach: streamlining regulations for efficient R&D, embracing global knowledge by partnering with international bodies, promoting knowledge sharing amongst a diverse range of global players, and ensuring patient safety through rigorous oversight.
This focus on collaboration and universal knowledge-sharing will not only cultivate a thriving industry within the UAE, but also accelerate access to life-saving treatments for patients worldwide. I am confident that through this shared journey, EDE will be a significant contributor as we propel the UAE to the forefront of the global healthcare landscape.

Dr. Maha Taysir Barakat
UAE Assistant Minister for Medical Affairs and Life Sciences
Vice Chairman, Board of Directors, Emirates Drug Establishment
Authority

Director General’s Message

From Innovative Regulation to Leadership: Emirates Drug Establishment redesigns sustainable healthcare future

The UAE is a global leader in innovation, attracting talent and accelerating the adoption of cutting-edge technologies. As part of this vision, the Emirates Drug Establishment (EDE) is at the forefront of safeguarding public health while advancing medical innovation.
As the UAE’s primary regulatory authority for pharmaceuticals, medical devices, and health-related technologies, EDE is dedicated to ensuring the safety, efficacy, and quality of healthcare solutions. EDE collaborates with global regulatory bodies, industry leaders, and research institutions to align with the highest standards and embrace the latest advancements in biotechnology, and R&D. By leveraging technologies like AI and data analytics, we streamline processes and enhance public health outcomes, ensuring access to the most advanced treatments in the world.   Beyond regulation, EDE is a key partner in national initiatives to enhance health and well-being. As we set new benchmarks in innovation, we remain committed to building a healthier, safer and future and sustainable wellbeing for all by establishing an integrated and sustainable health system.   We are also committed to realizing the vision of our wise leadership in establishing the UAE as a global model of excellence in healthcare. We are confident that this vision will be achieved through ongoing innovation, strategic collaboration, and adherence to the highest international standards.

Dr. Fatima Al Kaabi
Director General, Emirates Drug Establishment
Authority